Indoco Yet To See Predicted Revival In Domestic Business

As Company Reports 18% Revenue Growth Overall In Q3

India’s Indoco has reported double-digit growth despite a slow recovery of its domestic business during its financial third quarter ended 31 December 2020. The Indian company reported 18% sales growth overall, lifted by 73% growth in its International business in Q3. 

India_Mumbai
India’s Indoco Remedies continues to see consistent growth • Source: Shutterstock

Despite reporting consistent quarter-on-quarter growth, India’s Indoco Remedies Limited is yet to see an expected revival in its domestic business. After its sales in India took a hit over the past year due to COVID-19, the company had predicted growth based on “the bounce back of the Indian pharma market.”

However, commenting on the firm’s third-quarter results, Indoco’s managing director Aditi Panandikar said “While the revenue from International business has...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business